A Large Language Model in Outpatient Care

June 7, 2026 updated by: Tien Yin Wong, Tsinghua University

A Prospective Randomized Controlled Trial of a Large Language Model in Outpatient Care

The goal of this clinical trial is to learn how the use of a large language model (LLM) based tool affects outpatient clinical care in adult patients attending general hospital outpatient clinics. The main questions it aims to answer are:

Does the use of an LLM-based tool affect the efficiency of outpatient visits? Does the use of an LLM-based tool affect the experience of doctors and patients during outpatient care?

Researchers will compare outpatient visits supported by an LLM-based tool to standard outpatient visits without such a tool, to see whether and how the tool influences the care process and the experiences of doctors and patients.

Participants will:

Take part in outpatient visits that may or may not involve an LLM-based tool, depending on their assigned group Complete a short questionnaire about their visit experience after the consultation

Study Overview

Study Type

Interventional

Enrollment (Estimated)

3500

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Doctors:

  1. Licensed physicians providing outpatient consultations at a participating study hospital
  2. Expected to complete a sufficient number of outpatient clinic sessions during the study period
  3. Provides written informed consent

Patients:

  1. Age 18 years or older
  2. Attending an outpatient consultation with a participating doctor
  3. Able to interact with the tool using an internet-connected device such as a smartphone
  4. Provides written informed consent

Exclusion Criteria:

Patients:

  1. Psychiatric conditions, unstable vital signs, or other medical situations considered unsuitable for AI-based interaction
  2. Declines to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard Outpatient Care (No AI)
Neither doctors nor patients use a large language model based tool. Outpatient consultations and documentation are conducted following routine clinical practice.
Experimental: Outpatient Care With a Large Language Model Tool
Before the consultation, patients complete an AI-based pre-consultation interaction. During the visit, a large language model based tool is available to support the outpatient consultation process. Doctors may refer to the tool during the visit.
A large language model based tool is introduced into the outpatient consultation workflow to support the consultation and documentation process.
Experimental: Outpatient Care With a Large Language Model Tool and Workflow Support
Before the consultation, patients complete an AI-based pre-consultation interaction. During the visit, a large language model based tool is used together with additional workflow support to integrate the tool's output into the outpatient consultation process.
Additional workflow support is provided to integrate the output of the large language model based tool into the consultation process, approximating a more integrated deployment of the tool.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of the Outpatient Consultation
Time Frame: During the outpatient visit
Time of the outpatient consultation, measured in milliseconds
During the outpatient visit
Doctor-Reported Efficiency of the Consultation
Time Frame: Immediately after the consultation
Doctor's self-rated efficiency of the consultation, measured on a 5-point Likert scale (1 = very low to 5 = very high), with higher scores indicating higher perceived efficiency.
Immediately after the consultation
Doctor-Reported Satisfaction With the Consultation Process
Time Frame: Immediately after the consultation
Doctor's satisfaction with the consultation process, measured on a 5-point Likert scale (1 = very low to 5 = very high), with higher scores indicating higher satisfaction.
Immediately after the consultation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Doctor-Reported Efficiency of Obtaining Patient Information
Time Frame: Immediately after the consultation
Doctor's self-rated efficiency in obtaining the patient's clinical information (such as symptoms, history, prior examinations) during the consultation, measured on a 5-point Likert scale (1 = very low to 5 = very high); higher scores indicate higher efficiency.
Immediately after the consultation
Doctor-Reported Cognitive Effort in Clinical Decision-Making
Time Frame: Immediately after the consultation
Doctor's self-rated cognitive effort invested in clinical decision-making during the consultation, measured on a 5-point Likert scale (1 = very low to 5 = very high); higher scores indicate greater effort.
Immediately after the consultation
Doctor-Reported Burden of Clinical Documentation
Time Frame: Immediately after the consultation
Doctor's self-rated burden of completing the outpatient medical record for the consultation, measured on a 5-point Likert scale (1 = very low to 5 = very high); higher scores indicate greater burden.
Immediately after the consultation
Doctor's Intention to Continue Using the Tool
Time Frame: Within 1 week after the participating doctor completes all enrolled consultations
Doctor's intention to continue using the large language model based tool in routine practice, measured on a 5-point Likert scale (1 = strongly unwilling to 5 = strongly willing); higher scores indicate stronger intention.
Within 1 week after the participating doctor completes all enrolled consultations
Patient Trust in the Physician
Time Frame: Immediately after the consultation
Patient's level of trust in the physician after the visit, measured on a 5-point Likert scale (1 = very low to 5 = very high); higher scores indicate greater trust.
Immediately after the consultation
Patient Satisfaction With the Visit
Time Frame: Immediately after the consultation
Patient's satisfaction with the visit, measured on a 5-point Likert scale (1 = very low to 5 = very high); higher scores indicate greater satisfaction.
Immediately after the consultation
Patient-Perceived Physician Attentiveness
Time Frame: Immediately after the consultation
Patient-perceived attentiveness of the physician during the visit, assessed by a multi-item measure and reported as a composite score on a 1-5 scale; higher scores indicate greater perceived attentiveness.
Immediately after the consultation
Patient Satisfaction With the AI Pre-Consultation (Arm 2 and Arm 3 )
Time Frame: Immediately after the consultation
Patient's satisfaction with the AI-based pre-consultation interaction, measured on a 5-point Likert scale (1 = very low to 5 = very high); higher scores indicate greater satisfaction. Assessed only in Arm 2 and Arm 3.
Immediately after the consultation
Patient's Intention to Use AI Pre-Consultation in the Future (Arm 2 and Arm 3)
Time Frame: Immediately after the consultation
Patient's intention to use AI-based pre-consultation again in the future, measured on a 5-point Likert scale (1 = strongly unwilling to 5 = strongly willing); higher scores indicate stronger intention. Assessed only in Arm 2 and Arm 3.
Immediately after the consultation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 12, 2026

Primary Completion (Estimated)

September 4, 2026

Study Completion (Estimated)

September 4, 2026

Study Registration Dates

First Submitted

May 29, 2026

First Submitted That Met QC Criteria

June 7, 2026

First Posted (Actual)

June 11, 2026

Study Record Updates

Last Update Posted (Actual)

June 11, 2026

Last Update Submitted That Met QC Criteria

June 7, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • THU-01-2026-0055

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Outpatient Care

Clinical Trials on Large Language Model Based Tool

Subscribe